Performance of an indigenous b-mercaptoethanolmodified antigen in comparison with a commercial reference in direct agglutination test for detection of canine visceral leishmaniasis
| dc.contributor.author | Semião-Santos, Saul | |
| dc.contributor.author | Barral Veloso, Laura | |
| dc.contributor.author | Paes de Andrade, Paulo | |
| dc.contributor.author | Almeida de Melo, Márcia | |
| dc.contributor.author | Martins, Luís | |
| dc.contributor.author | Marinho, Artur | |
| dc.contributor.author | Afonso de Almeida, José | |
| dc.contributor.author | Campino, Lénea | |
| dc.contributor.author | Harith, Abdallah | |
| dc.contributor.editor | Borriello, S. Peter | |
| dc.date.accessioned | 2015-02-10T12:23:02Z | |
| dc.date.available | 2015-02-10T12:23:02Z | |
| dc.date.issued | 2014-01 | |
| dc.description.abstract | We compared the performance of a locally produced b-mercaptoethanol-modified promastigote antigen (b-ME-Ag) of an indigenous Leishmania infantum strain against that of a trypsinized Leishmania donovani reference (REF-Ag) in the direct agglutination test (DAT) for detection of canine visceral leishmaniasis (CVL). One hundred and fifty-one serum samples collected from dogs belonging to four groups with different conditions were included. At a DAT titre of 1 : 320, statistically determined as optimal cut-off value for b-ME-Ag, and 1 : 160 for REF-Ag, a sensitivity and a specificity of 100% were estimated for b-ME-Ag in comparison with 96.6% and 100 %, respectively, for REF-Ag. Overall, levels of agglutination titres recorded for the two antigens were highly concordant (Cohen’s k50.879) in both the CVL and non-CVL groups. Based on current results, and ease experienced in processing the antigen and reading the test outcome, we recommend incorporation of b-ME-Ag in DAT for confirmation or exclusion of suspected CVL in dogs. | por |
| dc.identifier.authoremail | saulix@gmail.com | |
| dc.identifier.authoremail | laura.barral@vallee.com.br | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | longipalpis@gmail.com | |
| dc.identifier.authoremail | lmlm@uevora.pt | |
| dc.identifier.authoremail | aamr@uevora.pt | |
| dc.identifier.authoremail | afonso@uevora.pt | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | harith17@yahoo.com | |
| dc.identifier.citation | J Med Microbiol. 2014. 63:106-10. | por |
| dc.identifier.doi | 10.1099/jmm.0.063891-0 | |
| dc.identifier.scientificarea | 384 | por |
| dc.identifier.uri | http://hdl.handle.net/10174/12571 | |
| dc.language.iso | por | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Society for General Microbiology (SGM) | por |
| dc.rights | restrictedAccess | por |
| dc.subject | Leishmania | por |
| dc.subject | DAT | por |
| dc.subject | b-mercaptoethanolmodified | por |
| dc.subject | antigen | por |
| dc.title | Performance of an indigenous b-mercaptoethanolmodified antigen in comparison with a commercial reference in direct agglutination test for detection of canine visceral leishmaniasis | por |
| dc.type | article | por |
| degois.publication.firstPage | 106 | por |
| degois.publication.lastPage | 110 | por |
| degois.publication.location | UK | por |
| degois.publication.title | Journal of Medical Microbiology | por |
| degois.publication.volume | 63 | por |